HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Vladyslav Getman Franz Eckersberger Adelheid End Walter Klepetko Michael Rolf Mueller Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Getman, V. Articles by Mueller, M. R. Search for Related Content PubMed PubMed Citation Articles by Getman, V. Articles by Mueller, M. R. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2004;25:1107-1113
© 2004 Elsevier Science NL

Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment

Department of Cardiothoracic Surgery, University Hospital of Vienna, Waehringer Guertel 18-20, Vienna A-1090, Austria

Received 3 September 2003; received in revised form 13 February 2004; accepted 20 February 2004.

^* Corresponding author. Tel./fax: +43-1-40400-5680
e-mail: michael-rolf.mueller{at}akh-wien.ac.at

Objective: To compare survival of patients with isolated synchronous and metachronous brain metastases from non-small cell lung cancer (NSCLC) after combined surgical treatment. Methods: A total of 991 patients underwent surgical resection of primary NSCLC between January 1994 and November 1999. Out of these, 32 patients (21 males and 11 females) were further treated for isolated brain metastases. In a retrospective survey, the outcome of patients with either synchronous (group 1, n=16) or metachronous (group 2, n=16) brain metastases was evaluated. Five patients out of each group received either adjuvant or neo-adjuvant chemotherapy. Data analysis includes descriptive statistics, Wilcoxon test, Kaplan–Meier method and Cox's proportional hazards model. Results: There was no significant difference in local tumour stage and histology of the primary tumour between both groups. Median of the disease free interval (DFI) after primary lung surgery (group 2) was 10 months, range 3–60 months. Median survival after lung surgery was 8.5 months in group 1 and 16.4 months in group 2 (P=0.094). Median survival after cerebral procedures was 9.3 and 6.2 months, respectively (P=0.127). Estimated survival rates by Kaplan–Meier method after cerebral procedures operation in group 1 were 37.5% at 1 year, 25.0% at 2 years and 18.8% at 5 years; in group 2 estimated survival rates were 31.3% at 1 year, 15.6% at 2 years and 0% at 5 years (P=0.148). Calculated survival rates after lung surgery were identical in group 1; in group 2 survival rates were 62.5, 43.8 and 18.8% at 1, 2 and 5 years, respectively (P=0.101). In the univariate model, none of the following variables had effect on survival: sex, age, T stage of the tumour, nodal status, timing of metastatic lesions, number of cerebral metastases, complete resection of primary tumour and histological type. Multivariate analysis did not reveal any risk factor, which significantly predicted survival. DFI did not correlate with survival of patients in group 2. Conclusions: Once isolated synchronous or metachronous brain metastases from NSCLC have developed, there is no difference in prognosis after combined surgery between analysed groups. This questions the value of lung resection in patients with isolated synchronous brain metastases.

Key Words: Lung cancer • Brain metastasis • Surgical treatment